4142.TW

Adimmune Corp · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$13.91B

PE Ratio

31.909740123754222

EV to Ebitda

—

Earnings Yield

3.13%

Revenue (TTM)

$80.9M

Net Income (TTM)

$17.3M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

44.30%

Profit Margin

21.35%

Return on Equity

—

Debt to Equity Ratio

0.36119793649356174

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$13.91B

Revenue TTM$80.9M

Shares Outstanding421.5M

Float353790464

Insider Ownership16.91%

Institutional Ownership15.86%

Growth Estimates8 fields›

Revenue Growth (Quarterly YoY)44.30%

Rev Growth Est 1Y Forward0.1890

EPS Growth (Quarterly YoY)164.90%

EPS Growth Est Quarterly0.47

LT EPS Growth Estimates0.00%

EBITDA Growth (Quarterly YoY)119.05%

CFO Growth (Quarterly YoY)-15.15%

FCF Growth (Quarterly YoY)-62.73%

Operations22 fields›

Revenue TTM$80.9M

Gross Margin TTM18.87%

Gross Margin (Quarterly)51.10%

Operating Margin TTM7.83%

Operating Margin (Quarterly)32.51%

Operating Expenses TTM$0.61M

Profit Margin TTM21.35%

Profit Margin (Quarterly)38.58%

Net Income TTM$17.3M

EPS TTM1.2

EPS (Quarterly)0.995276483483113

EBIT Margin TTM17.10%

EBITDA Margin TTM17.10%

EBITDA Margin (Quarterly)44.05%

EBITDA TTM$13.8M

CFO % of Revenue TTM-13.06%

CFO % of Revenue (Quarterly)-33.96%

CFO TTM$-10.6M

Capex % of Revenue TTM20.55%

Capital Expenditures$16.6M

FCF % of Revenue (Quarterly)-53.90%

FCF TTM$-15.3M

Efficiency1 fields›

ROA1.39%

Valuation12 fields›

P/E (TTM)31.909740123754222

P/E Forward0

PEG0

P/CFO-52.17073003773867

P/FCF-35.951110134578414

EV/Revenues (TTM)6.2752

Price To Book2.6855625837588226

Price to Tangible Book2.6855625837588226

Earnings Yield3.13%

FCF Yield-2.78%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity6 fields›

Current Ratio12.779416913546997

Total Assets$303.0M

Total Liabilities$288.1M

Shareholders Equity$205.2M

Debt to Equity0.36119793649356174

Interest Expense$0.61M

Yields4 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield3.13%

Buyback Yield-0.70%